Apotea AB (publ)

kr 104.30As of Sun 8 Nov 2026, 12:00 UTC
STO:APOTEAHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 0.58%
ROE 26.98%
Pharmaceutical Retailers
Beta (5Y) —
PE TTM 41.93
TSR TTM 26.80%
Mkt cap kr 10.85B
ROIC 22.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 118
13.21%
(36.02%)
Hold 7|6|10|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.99
0.98
1.02
1.06
(0.43%)
(2.80%)
(2.28%)
5.69%
Revenuekr B
1.199
1.269
1.237
1.286
(1.28%)
7.32%
6.99%
11.08%
Peers (US$1.097B)
Cap (US$)
PE
6.194B
24.94x
1.259B
21.09x
107.2M
12.24x
Capital
TTM
5Y
10Y
Leveragex
0.083
0.120
0.082
EBIT/Intx
1.733
0.183
0.170
Own earn%
470.02
(82.56)
(97.62)
Sh yield%
34.98
33.30
35.54
Owners
Insiders/Inst%
13.33
70.85
Short interest%
4.60
SBC / revenue%
2.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
11–19
$1 testx
16.1
Incr. ROIC%
15